Moneycontrol PRO
Loans
Loans
HomeNewsHivAids

Hiv/aids

Jump to
  • World Aids Day 2024: Prevent HIV, follow these critical tips for safer sex, healthier life

    The World AIDS Day serves as a reminder of the importance of prevention. Effective methods, such as consistent condom use, PrEP, regular testing, and harm reduction strategies, can help lower HIV transmission rates.

  • World AIDS Vaccine Day: Date, history, significance and quotes

    World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day, is observed on May 18 annually to mobilise greater support for the development of an AIDS vaccine.

  • World AIDS Day 2022: 5 celebrities who battled AIDS

    In honour of World AIDS Day, a look at celebrities who dealt with the chronic immune disease.

  • Govt unlikely to bring GST bills soon

    The government is keen to push the passage of three legislations related to the main GST bill in the ongoing Winter session, as Parliamentary nod for these bills is must for rolling out GST from the target date of April 1, 2017.

  • Tuberculosis: No more a poor man‘s disease

    The numbers say it all. In 2014, tuberculosis rivalled HIV Aids as the leading cause of death from infectious diseases according to a World Health Organisation report.

  • Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets

    The approval by the United States Food and Drug Administration (USFDA) is for an innovative formulation — Lopinavir/Ritonavir 40mg/ 10 mg oral pellets, Cipla said in a statement.

  • Experts divided over compulsory drug licence dispute

    By granting compulsory license to Natco for Bayer's kidney cancer drug Nexavar, the Indian government has opened a legal can of worms, reports CNBC-TV18's Archana Shukla.

  • Compulsory license forces MNC pharma to rework India plan

    Compulsory license granted to Natco has left the Indian pharma industry with a hard choice to make - cut prices, or quit selling the drug. To counter this drug-makers are changing strategies, reports CNBC-TV18's Archana Shukla.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347